Bio-Rad Laboratories Earnings
NYSE: BIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$2.61
Bio-Rad Laboratories earnings summary
Bio-Rad Laboratories is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $2.61. In its most recent report on Aug 4, 2026 (Q2 2026), BIO posted EPS of $13.85. Revenue for the quarter was $651.0 million.
Quarterly EPS is up 18.7% from the same quarter a year earlier. Across the last 16 reports, BIO shares moved an average of 3.0% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
BIO earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $13.85 | — | +1.1% |
| Apr 30, 2026 | — | $-19.55 | — | -0.9% |
| Feb 13, 2026 | — | $26.59 | — | +5.7% |
| Oct 29, 2025 | — | $-12.70 | — | -4.4% |
| Jul 31, 2025 | — | $11.67 | — | -7.2% |
| May 1, 2025 | — | $2.29 | — | +1.0% |
| Feb 14, 2025 | — | $-25.57 | — | +1.1% |
| Oct 31, 2024 | — | $23.34 | — | +0.2% |
| Aug 2, 2024 | — | $-76.26 | — | -3.2% |
| May 8, 2024 | — | $13.45 | — | +4.2% |
| Feb 16, 2024 | — | $12.14 | — | -0.7% |
| Oct 27, 2023 | — | $3.64 | — | +6.4% |
| Aug 4, 2023 | — | $-39.59 | — | -0.7% |
| May 5, 2023 | — | $2.32 | — | -3.3% |
| Feb 17, 2023 | — | $27.78 | — | -0.7% |
| Oct 28, 2022 | — | $-5.48 | — | +6.7% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.